
Studying the diseases of the brain is a massive challenge for researchers as extracting brain cells, or neurons, from a living patient is difficult and risky. At the same time, examining a patient's brain post-mortem usually only reveals the disease's final stages. And animal models, while incredibly informative, have frequently fallen short during the crucial drug-development stage of research. But scientists at the Gladstone Institutes and the University of California, ...
Read More